Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome
Clinical trial NCT02906371 · COMPLETED
Trial details
- NCT number
- NCT02906371
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-03-11
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.